Octave Bioscience's last reported valuation, Jul 2023. Nothing priced has surfaced since.
- ·The complete investor list: 18 names
- ·Watch Octave Bioscience: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Octave Bioscience funding history
5 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Mar 2025 | Early Stage VC | $31.8M | ▮ | ▮ |
| Sep 2023 | Early Stage VC | $7.0M | ▮ | ▮ |
| Jan 2023 | Early Stage VC | $32.5M | ▮ | ▮ |
| Oct 2020 | Early Stage VC | $32.0M | ▮ | ▮ |
| Nov 2014 | Seed Round | $2.5M | ▮ | ▮ |
Membership and data by Private Market View
Octave Bioscience valuation
Octave Bioscience's last reported valuation was $143 million in Jul 2023. No priced round, secondary trade or fund mark has surfaced since.
How much has Octave Bioscience raised?
Octave Bioscience has raised $129 million across 5 recorded rounds since 2014. The largest was a $7 million early-stage round in Sep 2023; the most recent was a $31.8 million early-stage round in Mar 2025.
Octave Bioscience has filed 5 Form Ds with the SEC since 2017, most recently in Mar 2025 ($31.8 million sold to 20 investors).
How Octave Bioscience's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Octave Bioscience, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about Octave Bioscience
- What is Octave Bioscience worth?
- Octave Bioscience is valued at $143.0M as of Oct 2026. Octave Bioscience's last reported valuation, Jul 2023. Nothing priced has surfaced since.
- How much has Octave Bioscience raised?
- Octave Bioscience has raised $129.2M in total funding across 5 recorded rounds.
- When did Octave Bioscience last raise?
- Octave Bioscience last raised in Mar 2025 (Early Stage VC), raising $31.8M.